191 related articles for article (PubMed ID: 33164337)
1. Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Stargardt's disease and dry age-related macular degeneration.
Julien-Schraermeyer S; Illing B; Tschulakow A; Taubitz T; Guezguez J; Burnet M; Schraermeyer U
Pharmacol Res Perspect; 2020 Dec; 8(6):e00683. PubMed ID: 33164337
[TBL] [Abstract][Full Text] [Related]
2. Removal of RPE lipofuscin results in rescue from retinal degeneration in a mouse model of advanced Stargardt disease: Role of reactive oxygen species.
Fang Y; Taubitz T; Tschulakow AV; Heiduschka P; Szewczyk G; Burnet M; Peters T; Biesemeier A; Sarna T; Schraermeyer U; Julien-Schraermeyer S
Free Radic Biol Med; 2022 Mar; 182():132-149. PubMed ID: 35219849
[TBL] [Abstract][Full Text] [Related]
3. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.
Radu RA; Mata NL; Nusinowitz S; Liu X; Sieving PA; Travis GH
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4742-7. PubMed ID: 12671074
[TBL] [Abstract][Full Text] [Related]
4. Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys.
Julien S; Schraermeyer U
Neurobiol Aging; 2012 Oct; 33(10):2390-7. PubMed ID: 22244091
[TBL] [Abstract][Full Text] [Related]
5. Increased cone sensitivity to ABCA4 deficiency provides insight into macular vision loss in Stargardt's dystrophy.
Conley SM; Cai X; Makkia R; Wu Y; Sparrow JR; Naash MI
Biochim Biophys Acta; 2012 Jul; 1822(7):1169-79. PubMed ID: 22033104
[TBL] [Abstract][Full Text] [Related]
6. Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.
Radu RA; Mata NL; Nusinowitz S; Liu X; Travis GH
Novartis Found Symp; 2004; 255():51-63; discussion 63-7, 177-8. PubMed ID: 14750596
[TBL] [Abstract][Full Text] [Related]
7. C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease.
Ma L; Kaufman Y; Zhang J; Washington I
J Biol Chem; 2011 Mar; 286(10):7966-7974. PubMed ID: 21156790
[TBL] [Abstract][Full Text] [Related]
8. Iron accumulation in Bruch's membrane and melanosomes of donor eyes with age-related macular degeneration.
Biesemeier A; Yoeruek E; Eibl O; Schraermeyer U
Exp Eye Res; 2015 Aug; 137():39-49. PubMed ID: 26026877
[TBL] [Abstract][Full Text] [Related]
9. Fundus autofluorescence in the Abca4(-/-) mouse model of Stargardt disease--correlation with accumulation of A2E, retinal function, and histology.
Charbel Issa P; Barnard AR; Singh MS; Carter E; Jiang Z; Radu RA; Schraermeyer U; MacLaren RE
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5602-12. PubMed ID: 23761084
[TBL] [Abstract][Full Text] [Related]
10. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).
Ramkumar HL; Zhang J; Chan CC
Prog Retin Eye Res; 2010 May; 29(3):169-90. PubMed ID: 20206286
[TBL] [Abstract][Full Text] [Related]
11. Dry age-related macular degeneration like pathology in aged 5XFAD mice: Ultrastructure and microarray analysis.
Park SW; Im S; Jun HO; Lee K; Park YJ; Kim JH; Park WJ; Lee YH; Kim JH
Oncotarget; 2017 Jun; 8(25):40006-40018. PubMed ID: 28467791
[TBL] [Abstract][Full Text] [Related]
12. Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration.
Mata NL; Tzekov RT; Liu X; Weng J; Birch DG; Travis GH
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1685-90. PubMed ID: 11431429
[TBL] [Abstract][Full Text] [Related]
13. Retina and RPE lipid profile changes linked with ABCA4 associated Stargardt's maculopathy.
Farnoodian M; Bose D; Barone F; Nelson LM; Boyle M; Jun B; Do K; Gordon W; Guerin MK; Perera R; Ji JX; Cogliati T; Sharma R; Brooks BP; Bazan NG; Bharti K
Pharmacol Ther; 2023 Sep; 249():108482. PubMed ID: 37385300
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Manganese Peroxidase Reduces A2E Burden in Age-Related and Stargardt's Macular Degeneration Models.
Moody KJ; Tinklepaugh J; Obert E; Grohn K; DeRosa JR; Lumen E; Moyer BS; Campbell S; Wolfe AJ; Sleeper MB; Bianchi AH; Fisher C; Applegate J; Leary E; LeClair N; Wortel D; Doyle RP; Rohrer B; Blanden AR
Rejuvenation Res; 2018 Dec; 21(6):560-571. PubMed ID: 30516450
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal models of age-related macular degeneration and Stargardt disease.
Fontaine V; Monteiro E; Fournié M; Brazhnikova E; Boumedine T; Vidal C; Balducci C; Guibout L; Latil M; Dilda PJ; Veillet S; Sahel JA; Lafont R; Camelo S
Aging (Albany NY); 2020 Apr; 12(7):6151-6171. PubMed ID: 32255762
[TBL] [Abstract][Full Text] [Related]
16. Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2).
Bakall B; Radu RA; Stanton JB; Burke JM; McKay BS; Wadelius C; Mullins RF; Stone EM; Travis GH; Marmorstein AD
Exp Eye Res; 2007 Jul; 85(1):34-43. PubMed ID: 17477921
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural alterations in the retinal pigment epithelium and photoreceptors of a Stargardt patient and three Stargardt mouse models: indication for the central role of RPE melanin in oxidative stress.
Taubitz T; Tschulakow AV; Tikhonovich M; Illing B; Fang Y; Biesemeier A; Julien-Schraermeyer S; Schraermeyer U
PeerJ; 2018; 6():e5215. PubMed ID: 30038866
[TBL] [Abstract][Full Text] [Related]
18. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle.
Racz B; Varadi A; Kong J; Allikmets R; Pearson PG; Johnson G; Cioffi CL; Petrukhin K
J Biol Chem; 2018 Jul; 293(29):11574-11588. PubMed ID: 29871924
[TBL] [Abstract][Full Text] [Related]
19. Chemiexcitation and melanin in photoreceptor disc turnover and prevention of macular degeneration.
Lyu Y; Tschulakow AV; Wang K; Brash DE; Schraermeyer U
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2216935120. PubMed ID: 37155898
[TBL] [Abstract][Full Text] [Related]
20. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.
Sachdeva MM; Eliott D
Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
